Literature DB >> 19620479

Are HER2 and TOP2A useful as prognostic or predictive biomarkers for anthracycline-based adjuvant chemotherapy for breast cancer?

Kathleen I Pritchard.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19620479     DOI: 10.1200/JCO.2009.22.8361

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  5 in total

1.  Alteration of topoisomerase II-alpha gene in human breast cancer: association with responsiveness to anthracycline-based chemotherapy.

Authors:  Michael F Press; Guido Sauter; Marc Buyse; Leslie Bernstein; Roberta Guzman; Angela Santiago; Ivonne E Villalobos; Wolfgang Eiermann; Tadeusz Pienkowski; Miguel Martin; Nicholas Robert; John Crown; Valerie Bee; Henry Taupin; Kerry J Flom; Isabelle Tabah-Fisch; Giovanni Pauletti; Mary-Ann Lindsay; Alessandro Riva; Dennis J Slamon
Journal:  J Clin Oncol       Date:  2010-12-28       Impact factor: 44.544

2.  The role of HER-2 in Breast Cancer.

Authors:  Takashi Ishikawa; Yasushi Ichikawa; Daisuke Shimizu; Takeshi Sasaki; Mikiko Tanabe; Takashi Chishima; Kazuaki Takabe; Itaru Endo
Journal:  J Surg Sci       Date:  2014-12

3.  Oral Etoposide and Trastuzumab Use for HER2-Positive Metastatic Breast Cancer: A Retrospective Study from the Institut Curie Hospitals.

Authors:  Clelia Chalumeau; Matthieu Carton; Alexandre Eeckhoutte; Stelly Ballet; Anne Vincent-Salomon; Perrine Vuagnat; Audrey Bellesoeur; Jean-Yves Pierga; Marc-Henri Stern; Francois-Clement Bidard; Florence Lerebours
Journal:  Cancers (Basel)       Date:  2022-04-24       Impact factor: 6.575

4.  HER2 and TOP2A in high-risk early breast cancer patients treated with adjuvant epirubicin-based dose-dense sequential chemotherapy.

Authors:  George Fountzilas; Christos Valavanis; Vassiliki Kotoula; Anastasia G Eleftheraki; Konstantine T Kalogeras; Olympia Tzaida; Anna Batistatou; Ralf Kronenwett; Ralph M Wirtz; Mattheos Bobos; Eleni Timotheadou; Nikolaos Soupos; George Pentheroudakis; Helen Gogas; Dimitrios Vlachodimitropoulos; Genovefa Polychronidou; Gerasimos Aravantinos; Angelos Koutras; Christos Christodoulou; Dimitrios Pectasides; Petroula Arapantoni
Journal:  J Transl Med       Date:  2012-01-12       Impact factor: 5.531

5.  Practical consensus recommendations on management of HR + ve early breast cancer with specific reference to genomic profiling.

Authors:  S Aggarwal; A Vaid; A Ramesh; Purvish M Parikh; S Purohit; B Avasthi; S Gupta; S Ranjan; V Kaushal; S Salim; R Singh; S Minhas; D Doval
Journal:  South Asian J Cancer       Date:  2018 Apr-Jun
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.